Current and Pending Support Eleanor M. Cicinsky 06 Jan 2003 07:51 EST
Hi,
I include the proposal being submitted and everything else major the faculty member has current or pending.
Eleanor Cicinsky
Temple University
Automatic digest processor wrote:
> There are 13 messages totalling 862 lines in this issue.
>
> Topics of the day:
>
> 1. Current & Pending Support (9)
> 2. Industry Research Grant Programs (2)
> 3. Position available
> 4. Grantsmanship Workshop
>
> ----------------------------------------------------------------------
>
> Date: Fri, 3 Jan 2003 08:24:48 -0600
> From: Valerie Seaquist <xxxxxx@EMAIL.UAH.EDU>
> Subject: Current & Pending Support
>
> Good Morning ListServers --
>
> When you are submitting current & pending support information with a
> proposal, do you include THAT proposal's information as part of your
> "pending" or just everything else that the PI (and other applicable
> personnel) has in other pending proposals?
>
> Thank you.
>
> Val Seaquist
> Office of Research Administration
> The University of Alabama in Huntsville
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 08:35:50 -0600
> From: Carole Robarchek <xxxxxx@WICHITA.EDU>
> Subject: Re: Current & Pending Support
>
> We include the current application so reviewers can judge whether the PI has time to complete the proposed project.
>
> Carole Robarchek
> Research Development Specialist
> Office of Research Administration
> Wichita State University
> (316) 978-6806
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 09:44:56 -0500
> From: Marie Smith <xxxxxx@ECOSTUDIES.ORG>
> Subject: Re: Current & Pending Support
>
> Good Morning
>
> We include the proposal being submitted as pending with the statement (this
> proposal) in parenthesis.
>
> Marie
>
> %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
> Marie F. Smith, CRA
> Manager of Grants Administration
> Institute of Ecosystem Studies
> PO Box AB, 65 Sharon Turnpike
> Millbrook, NY 12545
> Tel: 845-677-5343
> Direct Line: 845-677-7600 x 202
> FAX: 845-677-5976
> E-mail: xxxxxx@ecostudies.org
> http://www.ecostudies.org
>
> -----Original Message-----
> From: Valerie Seaquist [mailto:xxxxxx@EMAIL.UAH.EDU]
> Sent: Friday, January 03, 2003 9:25 AM
> To: xxxxxx@HRINET.ORG
> Subject: [RESADM-L] Current & Pending Support
>
> Good Morning ListServers --
>
> When you are submitting current & pending support information with a
> proposal, do you include THAT proposal's information as part of your
> "pending" or just everything else that the PI (and other applicable
> personnel) has in other pending proposals?
>
> Thank you.
>
> Val Seaquist
> Office of Research Administration
> The University of Alabama in Huntsville
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 09:42:44 -0500
> From: Jon Elizabeth Hart <xxxxxx@ROCKEFELLER.EDU>
> Subject: Re: Current & Pending Support
>
> Good morning!
>
> Ordinarily you don't include the present application in the list, but some
> instructions (RFP's/RFA's) tell you to do so. If we aren't specifically
> asked to include it, we don't.
> Joni.
>
> At 08:24 AM 1/3/03 -0600, you wrote:
> >Good Morning ListServers --
> >
> >When you are submitting current & pending support information with a
> >proposal, do you include THAT proposal's information as part of your
> >"pending" or just everything else that the PI (and other applicable
> >personnel) has in other pending proposals?
> >
> >Thank you.
> >
> >
> >Val Seaquist
> >Office of Research Administration
> >The University of Alabama in Huntsville
> >
> >
> >======================================================================
> > Instructions on how to use the RESADM-L Mailing List, including
> > subscription information and a web-searchable archive, are available
> > via our web site at http://www.hrinet.org (click on "Listserv Lists")
> >======================================================================
>
> Jon Hart, Senior Director, Sponsored Programs Administration
> The Rockefeller University
> 1230 York Ave.-Box 82, NY, NY 10021-6399
> tel: (212) 327-8054; fax: (212) 327-8400
> e-mail: xxxxxx@rockefeller.edu
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 08:49:04 -0600
> From: Michael Wetherholt <xxxxxx@MURRAYSTATE.EDU>
> Subject: Re: Current & Pending Support
>
> At Murray State, we do not include the proposal being submitted just
> everything else.
>
> Michael
>
> At 08:24 AM 01/03/2003 -0600, you wrote:
> >Good Morning ListServers --
> >
> >When you are submitting current & pending support information with a
> >proposal, do you include THAT proposal's information as part of your
> >"pending" or just everything else that the PI (and other applicable
> >personnel) has in other pending proposals?
> >
> >Thank you.
> >
> >
> >Val Seaquist
> >Office of Research Administration
> >The University of Alabama in Huntsville
> >
> >
> >======================================================================
> > Instructions on how to use the RESADM-L Mailing List, including
> > subscription information and a web-searchable archive, are available
> > via our web site at http://www.hrinet.org (click on "Listserv Lists")
> >======================================================================
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 09:59:30 -0500
> From: "Aull, Robert" <xxxxxx@IUPUI.EDU>
> Subject: Re: Current & Pending Support
>
> Val, per the PHS 398 instructions, page 42:
>
> "Neither the application under consideration nor the current PHS award for this project should be listed as other support."
>
> Robt Aull
> Indiana Univ
>
> -----Original Message-----
> From: Valerie Seaquist [mailto:xxxxxx@EMAIL.UAH.EDU]
> Sent: Friday, January 03, 2003 9:25 AM
> To: xxxxxx@HRINET.ORG
> Subject: [RESADM-L] Current & Pending Support
>
> Good Morning ListServers --
>
> When you are submitting current & pending support information with a
> proposal, do you include THAT proposal's information as part of your
> "pending" or just everything else that the PI (and other applicable
> personnel) has in other pending proposals?
>
> Thank you.
>
> Val Seaquist
> Office of Research Administration
> The University of Alabama in Huntsville
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 10:03:43 -0500
> From: Charlie Hathaway <xxxxxx@AECOM.YU.EDU>
> Subject: Re: Current & Pending Support
>
> >From NIH:
>
> "Neither the application under consideration nor the current PHS award for this project should be listed as other support."
>
> http://grants.nih.gov/grants/funding/phs398/section_3.html#b_other_support
>
> Charlie
>
> At 08:24 AM 1/3/03 -0600, you wrote:
> >Good Morning ListServers --
> >
> >When you are submitting current & pending support information with a
> >proposal, do you include THAT proposal's information as part of your
> >"pending" or just everything else that the PI (and other applicable
> >personnel) has in other pending proposals?
> >
> >Thank you.
> >
> >
> >Val Seaquist
> >Office of Research Administration
> >The University of Alabama in Huntsville
> >
> >
> >======================================================================
> > Instructions on how to use the RESADM-L Mailing List, including
> > subscription information and a web-searchable archive, are available
> > via our web site at http://www.hrinet.org (click on "Listserv Lists")
> >======================================================================
> >
> >
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 08:59:56 -0800
> From: Pat Hawk <xxxxxx@OHSU.EDU>
> Subject: Re: Current & Pending Support
>
> Happy New Year!
>
> Val, I think it depends on the sponsoring agency. If you look at NSF's Grant Proposal Guide, their instructions indicates the "proposed project and all other projects or activities requiring a portion of time of the PI and other senior personnel must be included, even if they receive no salary support ....." Based on other responses received on this question, NIH says they don't want it.
>
> Pat
>
> Patricia A. Hawk
> Assistant Director, Sponsored Projects Administration
> Oregon Health and Science University
> Mail Code AD220
> 2525 SW First Ave.,Suite 220
> Portland, OR 97201
> Voice: 503-494-3211
> Fax: 503-494-1191
> e-mail: xxxxxx@ohsu.edu
>
> >>> xxxxxx@EMAIL.UAH.EDU 01/03/03 06:24AM >>>
> Good Morning ListServers --
>
> When you are submitting current & pending support information with a
> proposal, do you include THAT proposal's information as part of your
> "pending" or just everything else that the PI (and other applicable
> personnel) has in other pending proposals?
>
> Thank you.
>
> Val Seaquist
> Office of Research Administration
> The University of Alabama in Huntsville
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 14:19:52 -0500
> From: Kim Vargas <xxxxxx@WFUBMC.EDU>
> Subject: Industry Research Grant Programs
>
> This is a multi-part message in MIME format.
>
> ------_=_NextPart_001_01C2B35D.176D8B24
> Content-Type: multipart/alternative;
> boundary="----_=_NextPart_002_01C2B35D.176D8B24"
>
> ------_=_NextPart_002_01C2B35D.176D8B24
> Content-Type: text/plain;
> charset="iso-8859-1"
> Content-Transfer-Encoding: quoted-printable
>
> I am currently working on an industry proposal with Pfizer, Inc. for the =
> Viagra Research Grants program that requires electronic submission by =
> the PI. One of the terms listed on the Program Guidelines website =
> states, "WITHOUT EXCEPTION, all intellectual property rights arising =
> from research funded by the Viagra Research Grants program shall be =
> owned by Pfizer, Inc. Each applicant and applicant's institution, if =
> applicable, will be required to transfer such rights to Pfizer, Inc. as =
> a condition of funding. If you are uncertain about these terms, please =
> consult your institution's legal representatives prior to submitting a =
> proposal." This term is of concern considering there is no contract =
> negotiation involved.
> =20
> Has anyone recently worked with Pfizer's research grant program or a =
> similar industry sponsored program? If so, how have you handled the IP =
> issue in situations such as this?
> =20
> Any comments or suggestions would be appreciated.
> =20
> Thanks,
> Kim
> =20
> Kim Vargas, MBA-HSA
> Research Grants Specialist, Office of Research
> Wake Forest University Health Sciences
> Medical Center Boulevard
> Winston-Salem, NC 27157
> Tel: (336) 716-0780
> Fax:(336) 716-4480
> xxxxxx@wfubmc.edu
> www.wfubmc.edu/or
>
> =20
>
> =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
>
> ------_=_NextPart_002_01C2B35D.176D8B24
> Content-Type: text/html;
> charset="iso-8859-1"
> Content-Transfer-Encoding: quoted-printable
>
> <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
> <HTML><HEAD><TITLE>Message</TITLE>
> <META http-equiv=3DContent-Type content=3D"text/html; =
> charset=3Diso-8859-1">
> <STYLE><!-- body { font-family: Arial, Helvetica; font-size: 10pt; =
> color: #000000; margin-top: 25px; margin-left: 25px; } P.msoNormal, =
> LI.msoNormal { font-family: Helvetica, "Times New Roman";
> font-size: 10pt;
> margin-top: 0px;
> margin-left: 0px;
> color: "#ffffcc";
> }
> -->
> </STYLE>
>
> <META content=3D"MSHTML 5.50.4919.2200" name=3DGENERATOR></HEAD>
> <BODY background=3Dcid:468201719@10012002-0994>
> <DIV>
> <DIV><FONT face=3D"Bookman Old Style" size=3D3><SPAN =
> class=3D328513918-10012002>I am=20
> currently working on an industry proposal with Pfizer, Inc. for the =
> Viagra=20
> Research Grants program that requires electronic submission by the=20
> PI. One of the terms listed on the Program =
> Guidelines=20
> website states, "WITHOUT EXCEPTION, all intellectual property =
> rights=20
> arising from research funded by the Viagra Research Grants program shall =
> be=20
> owned by Pfizer, Inc. Each applicant and applicant's institution, =
> if=20
> applicable, will be required to transfer such rights to Pfizer, Inc. as =
> a=20
> condition of funding. If you are uncertain about these terms, =
> please=20
> consult your institution's legal representatives prior to submitting a=20
> proposal." This term is of concern considering there is no =
> contract=20
> negotiation involved.</SPAN></FONT></DIV>
> <DIV><FONT face=3D"Bookman Old Style" size=3D3><SPAN=20
> class=3D328513918-10012002></SPAN></FONT> </DIV>
> <DIV><FONT face=3D"Bookman Old Style" size=3D3><SPAN =
> class=3D328513918-10012002><SPAN=20
> class=3D328513918-10012002>Has anyone recently worked with Pfizer's =
> research grant=20
> program or a similar industry sponsored program? If so, how =
> have you=20
> handled the IP issue in situations such as =
> this?</SPAN></SPAN></FONT></DIV>
> <DIV><FONT face=3D"Bookman Old Style" size=3D3><SPAN =
> class=3D328513918-10012002><SPAN=20
> class=3D328513918-10012002></SPAN></SPAN></FONT> </DIV>
> <DIV><FONT face=3D"Bookman Old Style" size=3D3><SPAN =
> class=3D328513918-10012002><SPAN=20
> class=3D328513918-10012002>Any comments or suggestions would be=20
> appreciated.</SPAN></SPAN></FONT></DIV>
> <DIV><FONT face=3D"Bookman Old Style" size=3D3><SPAN =
> class=3D328513918-10012002><SPAN=20
> class=3D328513918-10012002></SPAN></SPAN></FONT> </DIV>
> <DIV><FONT face=3D"Bookman Old Style" size=3D3><SPAN =
> class=3D328513918-10012002><SPAN=20
> class=3D328513918-10012002>Thanks,<BR>Kim</SPAN></SPAN></FONT></DIV></DIV=
> >
> <DIV> </DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" size=3D2>Kim Vargas,=20
> MBA-HSA</FONT></DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" size=3D2>Research =
> Grants=20
> Specialist, Office of Research</FONT></DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" size=3D2>Wake Forest =
> University=20
> Health Sciences</FONT></DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" size=3D2>Medical =
> Center=20
> Boulevard</FONT></DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" =
> size=3D2>Winston-Salem, NC=20
> 27157</FONT></DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" size=3D2>Tel: (336)=20
> 716-0780</FONT></DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" size=3D2>Fax:(336)=20
> 716-4480</FONT></DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" color=3D#000000 =
> size=3D2><A=20
> href=3D"mailto:xxxxxx@wfubmc.edu">xxxxxx@wfubmc.edu</A></FONT></DIV>
> <DIV align=3Dleft><FONT face=3D"Bookman Old Style" color=3D#000000 =
> size=3D2><A=20
> href=3D"http://www.wfubmc.edu/or">www.wfubmc.edu/or</A></FONT></DIV>
> <P> </P></BODY></HTML>
> <p>
> =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> =3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
> =00
> ------_=_NextPart_002_01C2B35D.176D8B24--
>
> ------_=_NextPart_001_01C2B35D.176D8B24
> Content-Type: image/gif;
> name="Blank Bkgrd.gif"
> Content-Transfer-Encoding: base64
> Content-ID: <xxxxxx@10012002-0994>
> Content-Description: Blank Bkgrd.gif
> Content-Location: Blank%20Bkgrd.gif
>
> R0lGODlhLQAtAID/AP////f39ywAAAAALQAtAEACcAxup8vtvxKQsFon6d02898pGkgiYoCm6sq2
> 7iqWcmzOsmeXeA7uPJd5CYdD2g9oPF58ygqz+XhCG9JpJGmlYrPXGlfr/Yo/VW45e7amp2tou/lW
> xo/zX513z+Vt+1n/tiX2pxP4NUhy2FM4xtjIUQAAOw==
>
> ------_=_NextPart_001_01C2B35D.176D8B24--
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 15:43:56 -0500
> From: Audrey Buck <xxxxxx@POBOX.UPENN.EDU>
> Subject: Re: Current & Pending Support
>
> We have our PIs put in the new proposal as pending since it has not been
> rejected or awarded at that time but will show the amount of effort
> that is proposed.
>
> Audrey
>
> Office of Research Services
> 3451 Walnut Street, Room P221 Franklin
> Philadelphia, PA 19104-6205
> (p) 215 573 6709
> (f) 215 898 9708
>
> -----Original Message-----
> From: Research Administration List [mailto:xxxxxx@HRINET.ORG] On
> Behalf Of Michael Wetherholt
> Sent: Friday, January 03, 2003 9:49 AM
> To: xxxxxx@HRINET.ORG
> Subject: Re: [RESADM-L] Current & Pending Support
>
> At Murray State, we do not include the proposal being submitted just
> everything else.
>
> Michael
>
> At 08:24 AM 01/03/2003 -0600, you wrote:
> >Good Morning ListServers --
> >
> >When you are submitting current & pending support information with a
> >proposal, do you include THAT proposal's information as part of your
> >"pending" or just everything else that the PI (and other applicable
> >personnel) has in other pending proposals?
> >
> >Thank you.
> >
> >
> >Val Seaquist
> >Office of Research Administration
> >The University of Alabama in Huntsville
> >
> >
> >======================================================================
> > Instructions on how to use the RESADM-L Mailing List, including
> > subscription information and a web-searchable archive, are available
> > via our web site at http://www.hrinet.org (click on "Listserv Lists")
> >======================================================================
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 15:38:36 -0500
> From: Jane Gruen <xxxxxx@PI.CPMC.COLUMBIA.EDU>
> Subject: Position available
>
> Business Manager
>
> Description:
> Reporting to the departmental administrator, the candidate has overall
> responsibility for both pre-award grant applications and post-award
> administration. He/she will serve as a liaison among principal
> investigators, granting agencies, the Office of Grants and Contracts
> and
> affiliated departments and institutions. Primary responsibilities
> include management of subcontracts, clinical trials and processing
> notices of awards. Must be able to disseminate information to faculty
> and support staff in a timely manner and produce ad hoc reports.
> Identify problems or potential problems, bringing them to the
> attention
> of the appropriate person. Supervise two other staff members.
>
> He or she should have expertise in Federal and non-Federal grants and
> contracts rules and regulations. Experience in non-profit or higher
> education areas greatly desired.
>
> Qualifications:
> Bachelor's degree. Minimum of three years in a similar position
> required.
>
> Skills:
> Strong analytic and problem-solving abilities; excellent interpersonal
> skills. Able to develop and manage diverse funding.
>
> AA/EOE
>
> e-mail: xxxxxx@pi.cpmc.columbia.edu
> fax: 212-543-6710
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 16:05:04 -0500
> From: "Blake\" A. \"Valerie" <xxxxxx@NSHS.EDU>
> Subject: Grantsmanship Workshop
>
> Dear Colleagues:
>
> Our Office of Grants and Contracts would like to sponsor a workshop on how
> to prepare a successful research grant application to the NIH. Have you
> offered this type of workshop at your Institution? If yes, did you bring in
> a consultant? Was the workshop successful? If you used a consultant, whom
> would you recommend? Your recommendations or comments on your experiences
> in this regard will be sincerely appreciated.
>
> Thanks and Happy New Year.
>
> Valerie A. Blake
> Assistant Director
> North Shore-Long Island Jewish Health System
> Office of Grants and Contracts
> 5 Dakota Drive, Suite 307
> Lake Success, NY 11042
> Phone: (516) 719-3100
> Fax: (516) 719-3110
> xxxxxx@nshs.edu
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> ------------------------------
>
> Date: Fri, 3 Jan 2003 16:42:03 -0500
> From: Joseph Broderick <xxxxxx@UMDNJ.EDU>
> Subject: Re: Industry Research Grant Programs
>
> --------------172DDCB63E4657649FD67CF9
> Content-Type: text/plain; charset=us-ascii
> Content-Transfer-Encoding: 7bit
>
> This provision is quite a troubling one. Not only do we find it
> unacceptable to waive intellectual property rights for the Pfizer-funded
> study, but the wording is vague enough that it implies that data
> generated cannot be used in future proposals to other sponsors, say NIH.
>
> Another objectionable aspect to this program is that submission is
> electronic and does not require institutional signoff.
>
> Kim Vargas wrote:
>
> > I am currently working on an industry proposal with Pfizer, Inc. for
> > the Viagra Research Grants program that requires electronic submission
> > by the PI. One of the terms listed on the Program Guidelines website
> > states, "WITHOUT EXCEPTION, all intellectual property rights arising
> > from research funded by the Viagra Research Grants program shall be
> > owned by Pfizer, Inc. Each applicant and applicant's institution, if
> > applicable, will be required to transfer such rights to Pfizer, Inc.
> > as a condition of funding. If you are uncertain about these terms,
> > please consult your institution's legal representatives prior to
> > submitting a proposal." This term is of concern considering there is
> > no contract negotiation involved.Has anyone recently worked with
> > Pfizer's research grant program or a similar industry sponsored
> > program? If so, how have you handled the IP issue in situations such
> > as this?Any comments or suggestions would be appreciated.Thanks,
> > Kim Kim Vargas, MBA-HSAResearch Grants Specialist, Office of
> > ResearchWake Forest University Health SciencesMedical Center
> > BoulevardWinston-Salem, NC 27157Tel: (336) 716-0780Fax:(336)
> > xxxxxx@wfubmc.eduwww.wfubmc.edu/or
> >
> > ======================================================================
> > Instructions on how to use the RESADM-L Mailing List, including
> > subscription information and a web-searchable archive, are available
> > via our web site at http://www.hrinet.org (click on "Listserv Lists")
> > ======================================================================
>
> --
> Joseph B. Broderick
> Grants and Contracts Administrator
> Office of Research and Sponsored Programs
> UMDNJ - Robert Wood Johnson Medical School
> 675 Hoes Lane, Room R109
> Piscataway, NJ 08854
> Phone: 732/235-2158 Fax: 732/235-5534
> Website: http://www2.umdnj.edu/orspweb
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> --------------172DDCB63E4657649FD67CF9
> Content-Type: multipart/related;
> boundary="------------E3A66032E2394C148807778E"
>
> --------------E3A66032E2394C148807778E
> Content-Type: text/html; charset=us-ascii
> Content-Transfer-Encoding: 7bit
>
> <!doctype html public "-//w3c//dtd html 4.0 transitional//en">
> <html>
> <body background="cid:part1.3E1603AB.727F31A7@umdnj.edu">
> This provision is quite a troubling one. Not only do we find it unacceptable
> to waive intellectual property rights for the Pfizer-funded study, but
> the wording is vague enough that it implies that data generated cannot
> be used in future proposals to other sponsors, say NIH.
> <br> Another objectionable aspect to this program is that submission
> is electronic and does not require institutional signoff.
> <p>Kim Vargas wrote:
> <blockquote TYPE=CITE><style><!-- body { font-family: Arial, Helvetica; font-size: 10pt; color: #000000; margin-top: 25px; margin-left: 25px; } P.msoNormal, LI.msoNormal { font-family: Helvetica, "Times New Roman";
> font-size: 10pt;
> margin-top: 0px;
> margin-left: 0px;
> color: "#ffffcc";
> }
> -->
> </style>
> <span class=328513918-10012002><font face="Bookman Old Style"><font size=+0>I
> am currently working on an industry proposal with Pfizer, Inc. for the
> Viagra Research Grants program that requires electronic submission by the
> PI. One of the terms listed on the Program Guidelines website states,
> "WITHOUT EXCEPTION, all intellectual property rights arising from research
> funded by the Viagra Research Grants program shall be owned by Pfizer,
> Inc. Each applicant and applicant's institution, if applicable, will
> be required to transfer such rights to Pfizer, Inc. as a condition of funding.
> If you are uncertain about these terms, please consult your institution's
> legal representatives prior to submitting a proposal." This term
> is of concern considering there is no contract negotiation involved.</font></font></span><span
> class=328513918-10012002></span><span class=328513918-10012002><span
> class=328513918-10012002><font face="Bookman Old Style"><font size=+0>Has
> anyone recently worked with Pfizer's research grant program or a similar
> industry sponsored program? If so, how have you handled the
> IP issue in situations such as this?</font></font></span></span><span class=328513918-10012002><span
> class=328513918-10012002></span></span><span class=328513918-10012002><span
> class=328513918-10012002><font face="Bookman Old Style"><font size=+0>Any
> comments or suggestions would be appreciated.</font></font></span></span><span class=328513918-10012002><span
> class=328513918-10012002></span></span><span class=328513918-10012002><span
> class=328513918-10012002><font face="Bookman Old Style"><font size=+0>Thanks,</font></font>
> <br><font face="Bookman Old Style"><font size=+0>Kim</font></font></span></span> <font face="Bookman Old Style"><font size=-1>Kim
> Vargas, MBA-HSA</font></font><font face="Bookman Old Style"><font size=-1>Research
> Grants Specialist, Office of Research</font></font><font face="Bookman Old Style"><font size=-1>Wake
> Forest University Health Sciences</font></font><font face="Bookman Old Style"><font size=-1>Medical
> Center Boulevard</font></font><font face="Bookman Old Style"><font size=-1>Winston-Salem,
> NC 27157</font></font><font face="Bookman Old Style"><font size=-1>Tel:
> (336) 716-0780</font></font><font face="Bookman Old Style"><font size=-1>Fax:(336)
> 716-4480</font></font><font face="Bookman Old Style"><font color="#000000"><font size=-1><a href="mailto:xxxxxx@wfubmc.edu">xxxxxx@wfubmc.edu</a></font></font></font><font face="Bookman Old Style"><font color="#000000"><font size=-1><a href="http://www.wfubmc.edu/or">www.wfubmc.edu/or</a></font></font></font>
> <p>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including subscription
> information and a web-searchable archive, are available via our web site
> at <A HREF="http://www.hrinet.org">http://www.hrinet.org</A> (click on "Listserv Lists") ======================================================================</blockquote>
>
> <p>--
> <br>Joseph B. Broderick
> <br>Grants and Contracts Administrator
> <br>Office of Research and Sponsored Programs
> <br>UMDNJ - Robert Wood Johnson Medical School
> <br>675 Hoes Lane, Room R109
> <br>Piscataway, NJ 08854
> <br> Phone: 732/235-2158 Fax: 732/235-5534
> <br> Website: <A HREF="http://www2.umdnj.edu/orspweb">http://www2.umdnj.edu/orspweb</A>
> <br>
> </body>
> </html>
> <p>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
> --------------E3A66032E2394C148807778E
> Content-Type: image/gif
> Content-ID: <xxxxxx@umdnj.edu>
> Content-Transfer-Encoding: base64
> Content-Disposition: inline; filename="Blank Bkgrd.gif"
>
> R0lGODlhLQAtAID/AP////f39ywAAAAALQAtAEACcAxup8vtvxKQsFon6d02898pGkgiYoCm
> 6sq27iqWcmzOsmeXeA7uPJd5CYdD2g9oPF58ygqz+XhCG9JpJGmlYrPXGlfr/Yo/VW45e7am
> p2tou/lWxo/zX513z+Vt+1n/tiX2pxP4NUhy2FM4xtjIUQAAOw==
> --------------E3A66032E2394C148807778E--
>
> --------------172DDCB63E4657649FD67CF9--
>
> ------------------------------
>
> End of RESADM-L Digest - 2 Jan 2003 to 3 Jan 2003 (#2003-3)
> ***********************************************************
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================